These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 38075202)

  • 1. Non-coding RNA-Mediated N6-Methyladenosine (m
    Hashemi M; Daneii P; Zandieh MA; Raesi R; Zahmatkesh N; Bayat M; Abuelrub A; Khazaei Koohpar Z; Aref AR; Zarrabi A; Rashidi M; Salimimoghadam S; Entezari M; Taheriazam A; Khorrami R
    Noncoding RNA Res; 2024 Mar; 9(1):84-104. PubMed ID: 38075202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.
    Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
    Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the reciprocal regulation of m
    Yang J; Liang F; Zhang F; Zhao H; Gong Q; Gao N
    Pharmacol Ther; 2024 Jul; 259():108671. PubMed ID: 38830387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the cross-talk between N6-methyladenosine modification and non-coding RNAs in breast cancer: Mechanisms and clinical implications.
    Liu X; Xie X; Sui C; Liu X; Song M; Luo Q; Zhan P; Feng J; Liu J
    Int J Cancer; 2024 Jun; 154(11):1877-1889. PubMed ID: 38429857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New understandings of the genetic regulatory relationship between non-coding RNAs and m
    Liu S; Xiang D
    Front Genet; 2023; 14():1270983. PubMed ID: 38125749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer.
    Lu S; Ding X; Wang Y; Hu X; Sun T; Wei M; Wang X; Wu H
    Front Cell Dev Biol; 2021; 9():772542. PubMed ID: 34938735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.
    Dou Z; Ma XT; Piao MN; Wang JP; Li JL
    Transl Cancer Res; 2024 Jun; 13(6):3106-3125. PubMed ID: 38988908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
    Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
    Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ramifications of m6A Modification on ncRNAs in Cancer.
    Mehmood R
    Curr Genomics; 2024 May; 25(3):158-170. PubMed ID: 39087001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The landscape of epigenetic regulation and therapeutic application of N
    Xu GE; Zhao X; Li G; Gokulnath P; Wang L; Xiao J
    Genes Dis; 2024 Sep; 11(5):101045. PubMed ID: 38988321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
    Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
    Front Oncol; 2022; 12():927640. PubMed ID: 35936737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
    Pan J; Huang T; Deng Z; Zou C
    Front Immunol; 2023; 14():1132601. PubMed ID: 36960074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impacts of Non-coding RNAs and N
    Xu Z; Ji G; Cui Y; Cui X
    Curr Cancer Drug Targets; 2021; 21(5):375-385. PubMed ID: 33475064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
    Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
    RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.
    Meng Q; Schatten H; Zhou Q; Chen J
    Aging (Albany NY); 2023 Jul; 15(13):6577-6619. PubMed ID: 37437245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functions of N6-methyladenosine modification in lncRNAs.
    He RZ; Jiang J; Luo DX
    Genes Dis; 2020 Dec; 7(4):598-605. PubMed ID: 33335959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between m6A and ncRNAs and Its Association with Diseases.
    Chen S; Dong J; Luo X; Nie Z; Lu S; Liu H; Liu J
    Cytogenet Genome Res; 2022; 162(4):171-187. PubMed ID: 36122561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk Between m6A RNA Methylation and miRNA Biogenesis in Cancer: An Unholy Nexus.
    Jayasree PJ; Dutta S; Karemore P; Khandelia P
    Mol Biotechnol; 2023 Oct; ():. PubMed ID: 37831403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
    Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
    Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer.
    Luo L; Zhen Y; Peng D; Wei C; Zhang X; Liu X; Han L; Zhang Z
    Cell Death Discov; 2022 Jul; 8(1):325. PubMed ID: 35851061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.